------------------------------------------------------------ Pratt version 2.1, Sept. 1996 Written by Inge Jonassen, University of Bergen Norway email: inge@ii.uib.no For more information, see http://www.ii.uib.no/~inge/Pratt.html ------------------------------------------------------------ Please quote: I.Jonassen, J.F.Collins, D.G.Higgins. Protein Science 1995;4(8):1587-1595. ------------------------------------------------------------ Pratt version 2.1 Analysing 21 sequences from file TM4 PATTERN CONSERVATION: CM: min Nr of Seqs to Match 21 C%: min Percentage Seqs to Match 100.0 PATTERN RESTRICTIONS : PP: pos in seq [off,complete,start] off PL: max Pattern Length 50 PN: max Nr of Pattern Symbols 50 PX: max Nr of consecutive x's 5 FN: max Nr of flexible spacers 2 FL: max Flexibility 2 FP: max Flex.Product 10 BI: Input Pattern Symbol File off BN: Nr of Pattern Symbols Initial Search 20 PATTERN SCORING: S: Scoring [info,mdl,tree,dist,ppv] info SEARCH PARAMETERS: G: Pattern Graph from [seq,al,query] seq E: Search Greediness 3 R: Pattern Refinement on RG: Generalise ambiguous symbols off OUTPUT: OF: Output Filename TM4.pratt2 OP: PROSITE Pattern Format on ON: max number patterns 20 OA: max number Alignments 20 M: Print Patterns in sequences off Sequence lengths: A15_HUMAN 244 CD37_HUMAN 281 CD37_RAT 281 CD53_HUMAN 219 CD53_RAT 218 CD63_HUMAN 237 CD63_MOUSE 237 CD63_RAT 237 CD81_HUMAN 236 CD81_MOUSE 236 CD82_HUMAN 267 CD82_MOUSE 266 CD9_BOVIN 225 CD9_CERAE 227 CD9_FELCA 225 CD9_HUMAN 227 CD9_MOUSE 225 CD9_RAT 225 CO02_HUMAN 237 IM23_SCHJA 218 IM23_SCHMA 218 Pratt run started at Thu Feb 6 21:27:08 1997 Best Patterns before refinement: fitness hits(seqs) Pattern 1: 12.5102 35( 21) C-C-G 2: 12.0102 37( 21) C-C-x(0,1)-G 3: 12.0102 40( 21) G-x(2)-F-x(2,3)-L 4: 12.0102 29( 21) G-x(0,1)-I-x(3)-V 5: 12.0102 22( 21) F-x(2,3)-C-x-G 6: 12.0102 28( 21) L-x(4)-L-x(0,1)-L 7: 11.5102 32( 21) L-L-x(0,2)-V 8: 11.5102 41( 21) L-x(0,1)-L-x(3,4)-A 9: 11.5102 29( 21) L-x(3,4)-V-x(4,5)-L 10: 11.5102 31( 21) F-x(2)-L-x(0,2)-I 11: 11.5102 36( 21) F-x(2)-L-x(0,2)-L 12: 11.5102 61( 21) F-x(3)-L-x(1,3)-I 13: 11.5102 26( 21) F-x(1,3)-C-x-G 14: 11.5102 26( 21) F-x(0,2)-C-x-G 15: 11.5102 29( 21) F-x(2,3)-C-x(0,1)-G 16: 11.5102 21( 21) Q-x(3,4)-C-x(1,2)-G 17: 11.5102 35( 21) I-x(2,3)-L-x(3,4)-L 18: 11.5102 36( 21) L-x(0,1)-L-x(0,1)-I 19: 11.5102 45( 21) L-x(0,1)-L-x(3,4)-L 20: 11.5102 33( 21) L-x(0,2)-L-x(3)-L Best Patterns (after refinement phase): fitness hits(seqs) Pattern A 1: 19.3829 21( 21) L-x(4)-L-x(0,1)-L-x(3)-[ATV]-x(3)-[AGLV]-[AGL] B 2: 16.4179 21( 21) F-x(2)-L-x(0,2)-L-x(4)-[AIV]-x(3)-[AGIV] C 3: 14.7096 30( 21) G-x(2)-F-x(2,3)-L-x(3)-[FIL] D 4: 13.7666 36( 21) F-[FILV]-x(2)-L-x(1,3)-I E 5: 13.7494 31( 21) L-x(0,1)-L-x(3,4)-L-x(4)-[AILV] F 6: 13.6910 37( 21) L-x(0,1)-L-x(3,4)-A-x(3)-[AGLV] G 7: 13.4312 24( 21) L-x(0,2)-L-x(3)-L-x(4)-[ACGTV] H 8: 12.5102 35( 21) C-C-G I 9: 12.0102 37( 21) C-C-x(0,1)-G J 10: 12.0102 29( 21) G-x(0,1)-I-x(3)-V K 11: 12.0102 22( 21) F-x(2,3)-C-x-G L 12: 11.5102 32( 21) L-L-x(0,2)-V M 13: 11.5102 29( 21) L-x(3,4)-V-x(4,5)-L N 14: 11.5102 31( 21) F-x(2)-L-x(0,2)-I O 15: 11.5102 26( 21) F-x(1,3)-C-x-G P 16: 11.5102 26( 21) F-x(0,2)-C-x-G Q 17: 11.5102 29( 21) F-x(2,3)-C-x(0,1)-G R 18: 11.5102 21( 21) Q-x(3,4)-C-x(1,2)-G S 19: 11.5102 35( 21) I-x(2,3)-L-x(3,4)-L T 20: 11.5102 36( 21) L-x(0,1)-L-x(0,1)-I Best patterns with alignements: fitness hits(seqs) Pattern A 1: 19.3829 21( 21) L-x(4)-L-x(0,1)-L-x(3)-[ATV]-x(3)-[AGLV]-[AGL] Occurences: 21(21) A15_HUMAN : 85- 101: pwmlk LyamfLsLvflAelvAG isgfv CD37_HUMAN : 89- 105: rcllg LyfgmLlLlfaTqitLG ilist CD37_RAT : 89- 105: rcllg LyfgmLlLlfaTqitLG ilist CD53_HUMAN : 88- 103: msffi LlliiL-LaevTlaiLL fvyeq CD53_RAT : 87- 102: msffv LllliL-LaevTlaiLL fvyek CD63_HUMAN : 12- 27: kcvkf LlyvlL-LafcAcavGL iavgv CD63_MOUSE : 12- 27: kcvkf LlyvlL-LafcAcavGL iaigv CD63_RAT : 12- 27: kcvkf LlyvlL-LafcAcavGL iaigv CD81_HUMAN : 197- 213: qkidd LfsgkLyLigiAaivVA vimif CD81_MOUSE : 197- 213: qkide LfsgkLyLigiAaivVA vimif CD82_HUMAN : 87- 103: rcllg LyfafLlLiliAqvtAG alfyf CD82_MOUSE : 87- 103: rcllg LyfvfLlLiliAqvtVG vlfyf CD9_BOVIN : 88- 103: qcmlg LffsfL-LvifAievAA aiwgy CD9_CERAE : 90- 105: qcmlg LffgfL-LvifAieiAA aiwgy CD9_FELCA : 88- 103: qcmlg LffgfL-LvifAieiAA aiwgy CD9_HUMAN : 90- 105: qcmlg LffgfL-LvifAieiAA aiwgy CD9_MOUSE : 88- 103: qcmlg LffgfL-LvifAieiAA avwgy CD9_RAT : 88- 103: qcmlg LffgfL-LvifAieiAA avwgy CO02_HUMAN : 92- 107: lffig LllilL-LqvaTgilGA vfksk IM23_SCHJA : 18- 33: scvfi LniicL-LcslVligAG ayvev IM23_SCHMA : 18- 33: scvfv LniicL-LcslVligAG ayvev B 2: 16.4179 21( 21) F-x(2)-L-x(0,2)-L-x(4)-[AIV]-x(3)-[AGIV] Occurences: 21(21) A15_HUMAN : 89- 104: klyam FlsLvfLaelvAgisG fvfrh CD37_HUMAN : 91- 106: llgly FgmLllLfatqItlgI listq CD37_RAT : 91- 106: llgly FgmLllLfatqItlgI listq CD53_HUMAN : 44- 59: nfgvl FhnLpsLtlgnVfviV gsiim CD53_RAT : 43- 58: tygil FrnLpfLtlgnVlviV gsiim CD63_HUMAN : 88- 103: itfai FlsLimLvevaAaiaG yvfrd CD63_MOUSE : 88- 103: itfai FlsLimLvevaVaiaG yvfrd CD63_RAT : 88- 103: itfai FlsLimLvevaVaiaG yvfrd CD81_HUMAN : 95- 110: llgtf FtcLviLfaceVaagI wgfvn CD81_MOUSE : 95- 110: llgtf FtcLviLfaceVaagI wgfvn CD82_HUMAN : 89- 102: llgly FafL--LliliAqvtA galfy CD82_MOUSE : 89- 102: llgly FvfL--LliliAqvtV gvlfy CD9_BOVIN : 90- 103: mlglf FsfL--LvifaIevaA aiwgy CD9_CERAE : 92- 105: mlglf FgfL--LvifaIeiaA aiwgy CD9_FELCA : 90- 103: mlglf FgfL--LvifaIeiaA aiwgy CD9_HUMAN : 92- 105: mlglf FgfL--LvifaIeiaA aiwgy CD9_MOUSE : 90- 103: mlglf FgfL--LvifaIeiaA avwgy CD9_RAT : 90- 103: mlglf FgfL--LvifaIeiaA avwgy CO02_HUMAN : 15- 30: ysmft FnfLfwLcgilIlalA iwvrv IM23_SCHJA : 196- 209: afgvc FfqL--LsiviAcclG qrihd IM23_SCHMA : 196- 209: afgvc FfqL--LsiviAcclG rqike C 3: 14.7096 30( 21) G-x(2)-F-x(2,3)-L-x(3)-[FIL] Occurences: 30(21) A15_HUMAN : 217- 227: agvaf GiaFsq-LigmL laccl CD37_HUMAN : 88- 98: lrcll GlyFgm-LlllF atqit CD37_RAT : 88- 98: lrcll GlyFgm-LlllF atqit CD53_HUMAN : 199- 210: vievl GmsFaltLncqI dktsq CD53_RAT : 198- 209: viqvl GmsFaltLncqI dktsq CD63_HUMAN : 211- 222: aaaal GiaFvevLgivF acclv CD63_HUMAN : 219- 230: fvevl GivFaccLvksI rsgye CD63_MOUSE : 211- 222: aaaal GiaFvevLgiiF scclv CD63_MOUSE : 219- 230: fvevl GiiFsccLvksI rsgye CD63_RAT : 211- 222: agaal GiaFvevLgiiF scclv CD63_RAT : 219- 230: fvevl GiiFsccLvksI rsgye CD81_HUMAN : 92- 102: sqcll GtfFtc-LvilF aceva CD81_MOUSE : 92- 102: sqcll GtfFtc-LvilF aceva CD82_HUMAN : 86- 96: vrcll GlyFaf-LlliL iaqvt CD82_HUMAN : 86- 97: vrcll GlyFaflLlilI aqvta CD82_MOUSE : 86- 96: vrcll GlyFvf-LlliL iaqvt CD82_MOUSE : 86- 97: vrcll GlyFvflLlilI aqvtv CD9_BOVIN : 87- 97: sqcml GlfFsf-LlviF aieva CD9_BOVIN : 207- 218: vvmif GmvFsmiLccaI rrnrd CD9_CERAE : 89- 99: sqcml GlfFgf-LlviF aieia CD9_CERAE : 209- 220: vvmif GmiFsmiLccaI rrnre CD9_FELCA : 87- 97: sqcml GlfFgf-LlviF aieia CD9_FELCA : 207- 218: vvmif GmiFsmiLccaI rrsre CD9_HUMAN : 89- 99: sqcml GlfFgf-LlviF aieia CD9_HUMAN : 209- 220: vvmif GmiFsmiLccaI rrnre CD9_MOUSE : 87- 97: sqcml GlfFgf-LlviF aieia CD9_MOUSE : 207- 218: vvmif GmiFsmiLccaI rrsre CD9_RAT : 87- 97: sqcml GlfFgf-LlviF aieia CD9_RAT : 207- 218: vvmif GmiFsmiLccaI rrsre CO02_HUMAN : 223- 234: vieil GlvFsmvLycqI gnk IM23_SCHJA : 193- 204: acvaf GvcFfqlLsivI acclg IM23_SCHMA : 193- 204: acvaf GvcFfqlLsivI acclg D 4: 13.7666 36( 21) F-[FILV]-x(2)-L-x(1,3)-I Occurences: 36(21) A15_HUMAN : 94- 102: flslv FLaeLvagI sgfvf CD37_HUMAN : 21- 29: fvfnl FFfvLgslI fcfgi CD37_RAT : 21- 29: fvfnl FFfvLgglI fcfgt CD53_HUMAN : 14- 22: lkyvl FFfnLlfwI cgcci CD53_HUMAN : 15- 22: kyvlf FFnlLfw-I cgcci CD53_HUMAN : 85- 91: cllms FFilLl--I illae CD53_HUMAN : 85- 92: cllms FFilLli-I llaev CD53_HUMAN : 86- 92: llmsf FIllLi--I llaev CD53_RAT : 84- 91: cllms FFvlLll-I llaev CD53_RAT : 85- 91: llmsf FVllLl--I llaev CD63_HUMAN : 214- 220: algia FVevLg--I vfacc CD63_MOUSE : 214- 220: algia FVevLg--I ifscc CD63_MOUSE : 214- 221: algia FVevLgi-I fsccl CD63_RAT : 214- 220: algia FVevLg--I ifscc CD63_RAT : 214- 221: algia FVevLgi-I fsccl CD81_HUMAN : 94- 100: cllgt FFtcLv--I lface CD81_MOUSE : 94- 100: cllgt FFtcLv--I lface CD82_HUMAN : 14- 22: tkyfl FLfnLiffI lgavi CD82_MOUSE : 14- 22: tkyfl FLfnLlffI lgavi CD82_MOUSE : 89- 95: llgly FVflLl--I liaqv CD82_MOUSE : 89- 97: llgly FVflLlilI aqvtv CD9_BOVIN : 18- 25: lfgfn FIfwLag-I avlsv CD9_BOVIN : 89- 96: cmlgl FFsfLlv-I faiev CD9_CERAE : 18- 25: lfgfn FIfwLag-I avlai CD9_CERAE : 91- 98: cmlgl FFgfLlv-I faiei CD9_FELCA : 18- 25: lfgfn FIfwLag-I avlav CD9_FELCA : 89- 96: cmlgl FFgfLlv-I faiei CD9_HUMAN : 18- 25: lfgfn FIfwLag-I avlai CD9_HUMAN : 91- 98: cmlgl FFgfLlv-I faiei CD9_MOUSE : 18- 25: lfgfn FIfwLag-I avlai CD9_MOUSE : 89- 96: cmlgl FFgfLlv-I faiei CD9_RAT : 18- 25: lfgfn FIfwLag-I avlai CD9_RAT : 89- 96: cmlgl FFgfLlv-I faiei CO02_HUMAN : 17- 24: mftfn FLfwLcg-I lilal CO02_HUMAN : 88- 95: cmlll FFigLll-I lllqv CO02_HUMAN : 89- 95: mlllf FIglLl--I lllqv IM23_SCHJA : 90- 96: ymyaf FLivLl--I aelva IM23_SCHJA : 196- 202: afgvc FFqlLs--I viacc IM23_SCHJA : 196- 204: afgvc FFqlLsivI acclg IM23_SCHMA : 90- 96: ymyaf FLvvLl--I aelaa IM23_SCHMA : 196- 202: afgvc FFqlLs--I viacc IM23_SCHMA : 196- 204: afgvc FFqlLsivI acclg E 5: 13.7494 31( 21) L-x(0,1)-L-x(3,4)-L-x(4)-[AILV] Occurences: 31(21) A15_HUMAN : 83- 95: gspwm LkLyamfLslvfL aelva CD37_HUMAN : 8- 20: aqesc LsLikyfLfvfnL fffvl CD37_HUMAN : 87- 99: elrcl LgLyfgmLlllfA tqitl CD37_RAT : 8- 20: aqesc LsLikyfLfvfnL fffvl CD37_RAT : 87- 99: elrcl LgLyfgmLlllfA tqitl CD53_HUMAN : 6- 18: mgmss LkLlkyvLfffnL lfwic CD53_HUMAN : 8- 18: msslk L-Lkyv-LfffnL lfwic CD53_HUMAN : 88- 99: msffi LlLiil-LaevtL aillf CD53_HUMAN : 88- 99: msffi L-LliilLaevtL aillf CD53_HUMAN : 89- 99: sffil L-Liil-LaevtL aillf CD53_RAT : 87- 98: msffv LlLlil-LaevtL aillf CD53_RAT : 87- 98: msffv L-LllilLaevtL aillf CD53_RAT : 88- 98: sffvl L-Llil-LaevtL aillf CD63_HUMAN : 12- 22: kcvkf L-Lyvl-LlafcA cavgl CD63_MOUSE : 12- 22: kcvkf L-Lyvl-LlafcA cavgl CD63_RAT : 12- 22: kcvkf L-Lyvl-LlafcA cavgl CD81_HUMAN : 44- 54: pqttn L-Lyle-LgdkpA pntfy CD81_MOUSE : 44- 54: pqtts L-Lyle-LgnkpA pntfy CD82_HUMAN : 85- 97: evrcl LgLyfafLllilI aqvta CD82_MOUSE : 18- 28: lflfn L-Lffi-LgaviL gfgvw CD82_MOUSE : 85- 97: evrcl LgLyfvfLllilI aqvtv CD9_BOVIN : 86- 98: esqcm LgLffsfLlvifA ievaa CD9_CERAE : 88- 100: esqcm LgLffgfLlvifA ieiaa CD9_FELCA : 86- 98: esqcm LgLffgfLlvifA ieiaa CD9_HUMAN : 88- 100: esqcm LgLffgfLlvifA ieiaa CD9_MOUSE : 86- 98: esqcm LgLffgfLlvifA ieiaa CD9_RAT : 86- 98: esqcm LgLffgfLlvifA ieiaa CO02_HUMAN : 85- 97: esrcm LlLffigLllilL lqvat CO02_HUMAN : 86- 97: srcml L-LffigLllilL lqvat IM23_SCHJA : 23- 34: lniic L-LcslvLigagA yvevk IM23_SCHJA : 94- 104: ffliv L-Liae-LvaaiV avvyk IM23_SCHMA : 23- 34: lniic L-LcslvLigagA yvevk IM23_SCHMA : 94- 104: fflvv L-Liae-LaaaiV avvyk F 6: 13.6910 37( 21) L-x(0,1)-L-x(3,4)-A-x(3)-[AGLV] Occurences: 37(21) A15_HUMAN : 90- 100: lyamf LsLvfl-AelvA gisgf CD37_HUMAN : 73- 83: tmgia L-LgcvgAlkeL rcllg CD37_RAT : 73- 83: tmala L-LgcvgAlkeL rcllg CD53_HUMAN : 88- 99: msffi LlLiillAevtL aillf CD53_HUMAN : 89- 99: sffil L-LiillAevtL aillf CD53_RAT : 87- 98: msffv LlLlillAevtL aillf CD53_RAT : 88- 98: sffvl LlLill-AevtL aillf CD53_RAT : 88- 98: sffvl L-LlillAevtL aillf CD53_RAT : 89- 98: ffvll L-Lill-AevtL aillf CD63_HUMAN : 16- 26: fllyv LlLafc-AcavG liavg CD63_HUMAN : 16- 26: fllyv L-LlafcAcavG liavg CD63_HUMAN : 17- 26: llyvl L-Lafc-AcavG liavg CD63_MOUSE : 16- 26: fllyv LlLafc-AcavG liaig CD63_MOUSE : 16- 26: fllyv L-LlafcAcavG liaig CD63_MOUSE : 17- 26: llyvl L-Lafc-AcavG liaig CD63_MOUSE : 203- 213: lrkni L-LvaaaAlgiA fvevl CD63_RAT : 16- 26: fllyv LlLafc-AcavG liaig CD63_RAT : 16- 26: fllyv L-LlafcAcavG liaig CD63_RAT : 17- 26: llyvl L-Lafc-AcavG liaig CD63_RAT : 203- 213: lrknv L-LvagaAlgiA fvevl CD81_HUMAN : 202- 212: lfsgk LyLigi-AaivV avimi CD81_HUMAN : 202- 213: lfsgk LyLigiaAivvA vimif CD81_MOUSE : 202- 212: lfsgk LyLigi-AaivV avimi CD81_MOUSE : 202- 213: lfsgk LyLigiaAivvA vimif CD82_HUMAN : 84- 94: nevrc L-LglyfAfllL iliaq CD82_HUMAN : 92- 102: lyfaf LlLili-AqvtA galfy CD82_HUMAN : 92- 102: lyfaf L-LliliAqvtA galfy CD82_HUMAN : 93- 102: yfafl L-Lili-AqvtA galfy CD82_MOUSE : 92- 102: lyfvf LlLili-AqvtV gvlfy CD82_MOUSE : 92- 102: lyfvf L-LliliAqvtV gvlfy CD82_MOUSE : 93- 102: yfvfl L-Lili-AqvtV gvlfy CD82_MOUSE : 230- 239: enfgi L-Lgvc-AgvaV iellg CD9_BOVIN : 93- 102: lffsf L-Lvif-AievA aaiwg CD9_CERAE : 95- 104: lffgf L-Lvif-AieiA aaiwg CD9_FELCA : 93- 102: lffgf L-Lvif-AieiA aaiwg CD9_HUMAN : 95- 104: lffgf L-Lvif-AieiA aaiwg CD9_MOUSE : 93- 102: lffgf L-Lvif-AieiA aavwg CD9_RAT : 93- 102: lffgf L-Lvif-AieiA aavwg CO02_HUMAN : 94- 105: figll LiLllqvAtgiL gavfk CO02_HUMAN : 96- 105: gllli L-Llqv-AtgiL gavfk IM23_SCHJA : 27- 38: cllcs LvLigagAyveV kfsqy IM23_SCHJA : 199- 209: vcffq L-LsiviAcclG qrihd IM23_SCHMA : 27- 38: cllcs LvLigagAyveV kfsqy IM23_SCHMA : 94- 104: fflvv L-LiaelAaaiV avvyk IM23_SCHMA : 199- 209: vcffq L-LsiviAcclG rqike G 7: 13.4312 24( 21) L-x(0,2)-L-x(3)-L-x(4)-[ACGTV] Occurences: 24(21) A15_HUMAN : 227- 237: qligm L--LaccLsrfiT anqye CD37_HUMAN : 80- 92: gcvga LkeLrclLglyfG mllll CD37_RAT : 80- 92: gcvga LkeLrclLglyfG mllll CD53_HUMAN : 88- 98: msffi L--LliiLlaevT laill CD53_RAT : 87- 97: msffv L--LlliLlaevT laill CD63_HUMAN : 12- 22: kcvkf L--LyvlLlafcA cavgl CD63_MOUSE : 12- 22: kcvkf L--LyvlLlafcA cavgl CD63_RAT : 12- 22: kcvkf L--LyvlLlafcA cavgl CD81_HUMAN : 44- 54: pqttn L--LyleLgdkpA pntfy CD81_MOUSE : 44- 54: pqtts L--LyleLgnkpA pntfy CD82_HUMAN : 243- 253: vaiie L--LgmvLsiclC rhvhs CD82_MOUSE : 13- 24: vtkyf Lf-LfnlLffilG avilg CD82_MOUSE : 242- 252: vavie L--LglfLsiclC ryihs CD9_BOVIN : 66- 78: igaga LmmLvgfLgccgA vqesq CD9_CERAE : 68- 80: igaga LmmLvgfLgccgA vqesq CD9_FELCA : 66- 78: igaga LmmLvgfLgccgA vqesq CD9_HUMAN : 68- 80: igaga LmmLvgfLgccgA vqesq CD9_MOUSE : 66- 78: igaga LmmLvgfLgccgA vqesq CD9_RAT : 66- 78: igaga LmmLvgfLgccgA vqesq CO02_HUMAN : 18- 30: ftfnf LfwLcgiLilalA iwvrv CO02_HUMAN : 92- 102: lffig L--LlilLlqvaT gilga CO02_HUMAN : 92- 103: lffig Ll-LillLqvatG ilgav CO02_HUMAN : 93- 103: ffigl L--LillLqvatG ilgav IM23_SCHJA : 94- 104: ffliv L--LiaeLvaaiV avvyk IM23_SCHMA : 94- 104: fflvv L--LiaeLaaaiV avvyk H 8: 12.5102 35( 21) C-C-G Occurences: 35(21) A15_HUMAN : 145- 147: qrsls CCG vqnyt CD37_HUMAN : 152- 154: qfqlr CCG whypq CD37_RAT : 152- 154: qfqlr CCG wqspr CD53_HUMAN : 144- 146: qsflq CCG ingts CD53_RAT : 143- 145: qsqlq CCG vngss CD63_HUMAN : 71- 73: vafvg CCG acken CD63_HUMAN : 144- 146: qadfk CCG aanyt CD63_MOUSE : 71- 73: vafvg CCG acken CD63_MOUSE : 144- 146: qkenn CCG asnyt CD63_RAT : 71- 73: vafvg CCG acken CD63_RAT : 144- 146: qkenk CCG asnyt CD81_HUMAN : 156- 158: hetld CCG sstlt CD81_HUMAN : 227- 229: lsmvl CCG irnss CD81_MOUSE : 156- 158: hetln CCG snalt CD81_MOUSE : 227- 229: lsmvl CCG irnss CD82_HUMAN : 149- 151: qaqvk CCG wvsfy CD82_MOUSE : 149- 151: qaqvk CCG wvshy CD9_BOVIN : 75- 77: vgflg CCG avqes CD9_BOVIN : 149- 151: hiald CCG ltgvp CD9_CERAE : 77- 79: vgflg CCG avqes CD9_CERAE : 151- 153: hyald CCG laggv CD9_FELCA : 75- 77: vgflg CCG avqes CD9_FELCA : 149- 151: hyald CCG laggv CD9_HUMAN : 77- 79: vgflg CCG avqes CD9_HUMAN : 151- 153: hyaln CCG laggv CD9_MOUSE : 75- 77: vgflg CCG avqes CD9_MOUSE : 149- 151: hmald CCG iagpl CD9_RAT : 75- 77: vgflg CCG avqes CD9_RAT : 149- 151: hmaln CCG iaggv CO02_HUMAN : 74- 76: lgflg CCG aikes CO02_HUMAN : 151- 153: qeefk CCG lvnga IM23_SCHJA : 73- 75: vsflg CCG aiken IM23_SCHJA : 144- 146: qtsfh CCG vkgpd IM23_SCHMA : 73- 75: vsflg CCG aiken IM23_SCHMA : 144- 146: qssfh CCG akgpd I 9: 12.0102 37( 21) C-C-x(0,1)-G Occurences: 37(21) A15_HUMAN : 145- 147: qrsls CC-G vqnyt CD37_HUMAN : 152- 154: qfqlr CC-G whypq CD37_RAT : 152- 154: qfqlr CC-G wqspr CD53_HUMAN : 144- 146: qsflq CC-G ingts CD53_RAT : 143- 145: qsqlq CC-G vngss CD63_HUMAN : 71- 73: vafvg CC-G acken CD63_HUMAN : 144- 146: qadfk CC-G aanyt CD63_MOUSE : 71- 73: vafvg CC-G acken CD63_MOUSE : 144- 146: qkenn CC-G asnyt CD63_RAT : 71- 73: vafvg CC-G acken CD63_RAT : 144- 146: qkenk CC-G asnyt CD81_HUMAN : 156- 158: hetld CC-G sstlt CD81_HUMAN : 227- 229: lsmvl CC-G irnss CD81_MOUSE : 156- 158: hetln CC-G snalt CD81_MOUSE : 227- 229: lsmvl CC-G irnss CD82_HUMAN : 149- 151: qaqvk CC-G wvsfy CD82_MOUSE : 149- 151: qaqvk CC-G wvshy CD9_BOVIN : 75- 77: vgflg CC-G avqes CD9_BOVIN : 149- 151: hiald CC-G ltgvp CD9_CERAE : 77- 79: vgflg CC-G avqes CD9_CERAE : 151- 153: hyald CC-G laggv CD9_FELCA : 75- 77: vgflg CC-G avqes CD9_FELCA : 149- 151: hyald CC-G laggv CD9_HUMAN : 77- 79: vgflg CC-G avqes CD9_HUMAN : 151- 153: hyaln CC-G laggv CD9_MOUSE : 75- 77: vgflg CC-G avqes CD9_MOUSE : 149- 151: hmald CC-G iagpl CD9_RAT : 75- 77: vgflg CC-G avqes CD9_RAT : 149- 151: hmaln CC-G iaggv CO02_HUMAN : 74- 76: lgflg CC-G aikes CO02_HUMAN : 151- 153: qeefk CC-G lvnga IM23_SCHJA : 73- 75: vsflg CC-G aiken IM23_SCHJA : 144- 146: qtsfh CC-G vkgpd IM23_SCHJA : 206- 209: sivia CClG qrihd IM23_SCHMA : 73- 75: vsflg CC-G aiken IM23_SCHMA : 144- 146: qssfh CC-G akgpd IM23_SCHMA : 206- 209: sivia CClG rqike J 10: 12.0102 29( 21) G-x(0,1)-I-x(3)-V Occurences: 29(21) A15_HUMAN : 25- 31: vfwit GvIllaV gvwgk A15_HUMAN : 101- 106: aelva G-IsgfV frhei A15_HUMAN : 209- 214: metnm G-IiagV afgia CD37_HUMAN : 247- 252: lisiv G-IclgV gllel CD37_RAT : 247- 252: iisiv G-IclgV gllel CD53_HUMAN : 60- 66: vfviv GsIimvV aflgc CD53_HUMAN : 186- 192: nflyi GiIticV cviev CD53_RAT : 30- 35: cilgf G-IhllV qntyg CD53_RAT : 59- 65: vlviv GsIimvV aflgc CD63_HUMAN : 26- 32: cacav GlIavgV gaqlv CD63_MOUSE : 26- 32: cacav GlIaigV avqvv CD63_RAT : 26- 32: cacav GlIaigV avqvv CD81_HUMAN : 109- 114: cevaa G-IwgfV nkdqi CD81_HUMAN : 206- 211: klyli G-IaaiV vavim CD81_MOUSE : 109- 114: cevaa G-IwgfV nkdqi CD81_MOUSE : 206- 211: klyli G-IaaiV vavim CD82_HUMAN : 229- 234: lqenl G-IilgV gvgva CD82_MOUSE : 228- 233: lqenf G-IllgV cagva CD9_BOVIN : 197- 202: iigav G-IgiaV vmifg CD9_CERAE : 199- 204: iigav G-IgiaV vmifg CD9_FELCA : 197- 202: iigav G-IgiaV vmifg CD9_HUMAN : 199- 204: iigav G-IgiaV vmifg CD9_MOUSE : 197- 202: iigav G-IgiaV vmifg CD9_RAT : 151- 156: alncc G-IaggV eqfis CD9_RAT : 197- 202: iigav G-IgiaV vmifg CO02_HUMAN : 103- 108: lqvat G-IlgaV fksks IM23_SCHJA : 75- 81: flgcc GaIkenV cmlym IM23_SCHMA : 62- 68: aiivv GvIiliV sflgc IM23_SCHMA : 75- 81: flgcc GaIkenV cmlym K 11: 12.0102 22( 21) F-x(2,3)-C-x-G Occurences: 22(21) A15_HUMAN : 73- 78: glfgc Fat-CrG spwml CD37_HUMAN : 148- 154: wdyvq FqlrCcG whypq CD37_RAT : 148- 154: wdyaq FqlrCcG wqspr CD53_HUMAN : 68- 73: imvva Flg-CmG siken CD53_HUMAN : 141- 146: dsiqs Flq-CcG ingts CD53_RAT : 67- 72: imvva Flg-CmG siken CD63_HUMAN : 68- 73: lflva Fvg-CcG acken CD63_MOUSE : 68- 73: lflva Fvg-CcG acken CD63_RAT : 68- 73: lflva Fvg-CcG acken CD81_HUMAN : 77- 82: mmfvg Flg-CyG aiqes CD81_MOUSE : 77- 82: mmfvg Flg-CyG aiqes CD82_HUMAN : 71- 76: tmlmg Flg-CiG avnev CD82_MOUSE : 71- 76: tivmg Flg-CiG avnev CD9_BOVIN : 72- 77: mmlvg Flg-CcG avqes CD9_CERAE : 74- 79: mmlvg Flg-CcG avqes CD9_FELCA : 72- 77: mmlvg Flg-CcG avqes CD9_HUMAN : 74- 79: mmlvg Flg-CcG avqes CD9_MOUSE : 72- 77: mmlvg Flg-CcG avqes CD9_RAT : 72- 77: mmlvg Flg-CcG avqes CO02_HUMAN : 71- 76: imilg Flg-CcG aikes IM23_SCHJA : 70- 75: ilivs Flg-CcG aiken IM23_SCHMA : 70- 75: ilivs Flg-CcG aiken L 12: 11.5102 32( 21) L-L-x(0,2)-V Occurences: 32(21) A15_HUMAN : 28- 31: itgvi LLa-V gvwgk CD37_HUMAN : 73- 77: tmgia LLgcV galke CD37_RAT : 73- 77: tmala LLgcV galke CD53_HUMAN : 8- 12: msslk LLkyV lfffn CD53_HUMAN : 93- 97: lllii LLaeV tlail CD53_HUMAN : 102- 105: vtlai LLf-V yeqkl CD53_RAT : 7- 11: msslk LLkyV lfffn CD53_RAT : 33- 35: gfgih LL--V qntyg CD53_RAT : 92- 96: lllli LLaeV tlail CD53_RAT : 101- 104: vtlai LLf-V yekki CD63_HUMAN : 12- 15: kcvkf LLy-V lllaf CD63_HUMAN : 51- 54: atpgs LLp-V viiav CD63_HUMAN : 51- 55: atpgs LLpvV iiavg CD63_MOUSE : 12- 15: kcvkf LLy-V lllaf CD63_MOUSE : 51- 54: ttags LLp-V viiav CD63_MOUSE : 51- 55: ttags LLpvV iiavg CD63_MOUSE : 203- 205: lrkni LL--V aaaal CD63_RAT : 12- 15: kcvkf LLy-V lllaf CD63_RAT : 51- 54: ttags LLp-V viiav CD63_RAT : 51- 55: ttags LLpvV iiavg CD63_RAT : 203- 205: lrknv LL--V agaal CD81_HUMAN : 13- 16: kciky LLf-V fnfvf CD81_MOUSE : 13- 16: kciky LLf-V fnfvf CD82_HUMAN : 243- 247: vaiie LLgmV lsicl CD82_MOUSE : 230- 233: enfgi LLg-V cagva CD9_BOVIN : 93- 95: lffsf LL--V ifaie CD9_CERAE : 95- 97: lffgf LL--V ifaie CD9_FELCA : 93- 95: lffgf LL--V ifaie CD9_HUMAN : 95- 97: lffgf LL--V ifaie CD9_MOUSE : 93- 95: lffgf LL--V ifaie CD9_RAT : 93- 95: lffgf LL--V ifaie CO02_HUMAN : 96- 100: gllli LLlqV atgil CO02_HUMAN : 97- 100: lllil LLq-V atgil IM23_SCHJA : 199- 203: vcffq LLsiV iaccl IM23_SCHMA : 199- 203: vcffq LLsiV iaccl M 13: 11.5102 29( 21) L-x(3,4)-V-x(4,5)-L Occurences: 29(21) A15_HUMAN : 28- 39: itgvi LlavgVwgkltL gtyis A15_HUMAN : 29- 39: tgvil Lavg-VwgkltL gtyis CD37_HUMAN : 73- 83: tmgia Llgc-VgalkeL rcllg CD37_RAT : 61- 71: twskv LsvsgVltma-L allgc CD37_RAT : 73- 83: tmala Llgc-VgalkeL rcllg CD37_RAT : 115- 124: tqrvr Lerr-Vqelv-L rtiqs CD53_HUMAN : 8- 18: msslk Llky-VlfffnL lfwic CD53_HUMAN : 93- 102: lllii Llae-Vtlai-L lfvye CD53_HUMAN : 93- 103: lllii Llae-VtlailL fvyeq CD53_RAT : 81- 92: enkcl LmsffVlllliL laevt CD53_RAT : 92- 101: lllli Llae-Vtlai-L lfvye CD53_RAT : 92- 102: lllli Llae-VtlailL fvyek CD63_HUMAN : 27- 38: acavg LiavgVgaqlvL sqtii CD63_MOUSE : 27- 38: acavg LiaigVavqvvL kqait CD63_RAT : 27- 38: acavg LiaigVavqvvL kqait CD81_HUMAN : 23- 33: nfvfw Lagg-VilgvaL wlrhd CD81_HUMAN : 165- 174: stlta Ltts-Vlknn-L cpsgs CD81_MOUSE : 23- 33: nfvfw Lagg-VilgvaL wlrhd CD82_HUMAN : 96- 105: fllli Liaq-Vtaga-L fyfnm CD82_HUMAN : 243- 252: vaiie Llgm-Vlsic-L crhvh CD82_MOUSE : 85- 96: evrcl LglyfVfllliL iaqvt CD82_MOUSE : 96- 105: fllli Liaq-Vtvgv-L fyfna CD9_BOVIN : 22- 32: nfifw LagiaVlsvg-L wlrfd CD9_CERAE : 22- 32: nfifw LagiaVlaig-L wlrfd CD9_FELCA : 22- 32: nfifw LagiaVlavg-L wlrfd CD9_HUMAN : 22- 32: nfifw LagiaVlaig-L wlrfd CD9_MOUSE : 22- 32: nfifw LagiaVlaig-L wlrfd CD9_RAT : 22- 32: nfifw LagiaVlaig-L wlrfd CO02_HUMAN : 96- 105: gllli Lllq-Vatgi-L gavfk IM23_SCHJA : 199- 208: vcffq Llsi-Viacc-L gqrih IM23_SCHMA : 199- 208: vcffq Llsi-Viacc-L grqik N 14: 11.5102 31( 21) F-x(2)-L-x(0,2)-I Occurences: 31(21) A15_HUMAN : 220- 224: afgia FsqL--I gmlla CD37_HUMAN : 51- 56: fvgla FvpLq-I wskvl CD37_HUMAN : 162- 166: ypqdw FqvL--I lrgng CD37_HUMAN : 259- 264: llelg FmtLs-I flcrn CD37_RAT : 259- 264: llelg FmtLs-I flcrn CD53_HUMAN : 16- 22: yvlff FnlLfwI cgcci CD53_HUMAN : 85- 91: cllms FfiLllI illae CD53_HUMAN : 86- 91: llmsf FilLl-I illae CD53_HUMAN : 86- 92: llmsf FilLliI llaev CD53_RAT : 85- 91: llmsf FvlLllI llaev CD63_HUMAN : 88- 92: itfai FlsL--I mlvev CD63_MOUSE : 88- 92: itfai FlsL--I mlvev CD63_RAT : 88- 92: itfai FlsL--I mlvev CD81_HUMAN : 95- 100: llgtf FtcLv-I lface CD81_MOUSE : 95- 100: llgtf FtcLv-I lface CD82_HUMAN : 89- 95: llgly FafLllI liaqv CD82_HUMAN : 91- 95: glyfa FllL--I liaqv CD82_HUMAN : 91- 97: glyfa FllLilI aqvta CD82_MOUSE : 16- 22: yflfl FnlLffI lgavi CD82_MOUSE : 89- 95: llgly FvfLllI liaqv CD82_MOUSE : 91- 95: glyfv FllL--I liaqv CD82_MOUSE : 91- 97: glyfv FllLilI aqvtv CD9_BOVIN : 90- 96: mlglf FsfLlvI faiev CD9_CERAE : 92- 98: mlglf FgfLlvI faiei CD9_FELCA : 90- 96: mlglf FgfLlvI faiei CD9_HUMAN : 92- 98: mlglf FgfLlvI faiei CD9_MOUSE : 90- 96: mlglf FgfLlvI faiei CD9_RAT : 90- 96: mlglf FgfLlvI faiei CO02_HUMAN : 89- 95: mlllf FigLllI lllqv IM23_SCHJA : 196- 202: afgvc FfqLlsI viacc IM23_SCHJA : 197- 202: fgvcf FqlLs-I viacc IM23_SCHMA : 134- 138: keite FmnL--I qssfh IM23_SCHMA : 196- 202: afgvc FfqLlsI viacc IM23_SCHMA : 197- 202: fgvcf FqlLs-I viacc O 15: 11.5102 26( 21) F-x(1,3)-C-x-G Occurences: 26(21) A15_HUMAN : 73- 78: glfgc Fat-CrG spwml CD37_HUMAN : 148- 154: wdyvq FqlrCcG whypq CD37_RAT : 148- 154: wdyaq FqlrCcG wqspr CD53_HUMAN : 68- 73: imvva Flg-CmG siken CD53_HUMAN : 141- 146: dsiqs Flq-CcG ingts CD53_RAT : 67- 72: imvva Flg-CmG siken CD63_HUMAN : 68- 73: lflva Fvg-CcG acken CD63_HUMAN : 142- 146: rmqad Fk--CcG aanyt CD63_MOUSE : 68- 73: lflva Fvg-CcG acken CD63_RAT : 68- 73: lflva Fvg-CcG acken CD81_HUMAN : 77- 82: mmfvg Flg-CyG aiqes CD81_MOUSE : 77- 82: mmfvg Flg-CyG aiqes CD82_HUMAN : 71- 76: tmlmg Flg-CiG avnev CD82_MOUSE : 71- 76: tivmg Flg-CiG avnev CD9_BOVIN : 72- 77: mmlvg Flg-CcG avqes CD9_CERAE : 74- 79: mmlvg Flg-CcG avqes CD9_FELCA : 72- 77: mmlvg Flg-CcG avqes CD9_HUMAN : 74- 79: mmlvg Flg-CcG avqes CD9_MOUSE : 72- 77: mmlvg Flg-CcG avqes CD9_RAT : 72- 77: mmlvg Flg-CcG avqes CO02_HUMAN : 71- 76: imilg Flg-CcG aikes CO02_HUMAN : 149- 153: vfqee Fk--CcG lvnga IM23_SCHJA : 70- 75: ilivs Flg-CcG aiken IM23_SCHJA : 142- 146: kiqts Fh--CcG vkgpd IM23_SCHMA : 70- 75: ilivs Flg-CcG aiken IM23_SCHMA : 142- 146: liqss Fh--CcG akgpd P 16: 11.5102 26( 21) F-x(0,2)-C-x-G Occurences: 26(21) A15_HUMAN : 73- 78: glfgc FatCrG spwml CD37_HUMAN : 30- 33: lgsli F--CfG iwili CD37_RAT : 30- 33: lggli F--CfG twili CD53_HUMAN : 68- 73: imvva FlgCmG siken CD53_HUMAN : 141- 146: dsiqs FlqCcG ingts CD53_RAT : 67- 72: imvva FlgCmG siken CD63_HUMAN : 68- 73: lflva FvgCcG acken CD63_HUMAN : 142- 146: rmqad Fk-CcG aanyt CD63_MOUSE : 68- 73: lflva FvgCcG acken CD63_RAT : 68- 73: lflva FvgCcG acken CD81_HUMAN : 77- 82: mmfvg FlgCyG aiqes CD81_MOUSE : 77- 82: mmfvg FlgCyG aiqes CD82_HUMAN : 71- 76: tmlmg FlgCiG avnev CD82_MOUSE : 71- 76: tivmg FlgCiG avnev CD9_BOVIN : 72- 77: mmlvg FlgCcG avqes CD9_CERAE : 74- 79: mmlvg FlgCcG avqes CD9_FELCA : 72- 77: mmlvg FlgCcG avqes CD9_HUMAN : 74- 79: mmlvg FlgCcG avqes CD9_MOUSE : 72- 77: mmlvg FlgCcG avqes CD9_RAT : 72- 77: mmlvg FlgCcG avqes CO02_HUMAN : 71- 76: imilg FlgCcG aikes CO02_HUMAN : 149- 153: vfqee Fk-CcG lvnga IM23_SCHJA : 70- 75: ilivs FlgCcG aiken IM23_SCHJA : 142- 146: kiqts Fh-CcG vkgpd IM23_SCHMA : 70- 75: ilivs FlgCcG aiken IM23_SCHMA : 142- 146: liqss Fh-CcG akgpd Q 17: 11.5102 29( 21) F-x(2,3)-C-x(0,1)-G Occurences: 29(21) A15_HUMAN : 73- 78: glfgc Fat-CrG spwml CD37_HUMAN : 148- 154: wdyvq FqlrCcG whypq CD37_RAT : 148- 154: wdyaq FqlrCcG wqspr CD53_HUMAN : 20- 24: ffnll Fwi-C-G ccilg CD53_HUMAN : 68- 73: imvva Flg-CmG siken CD53_HUMAN : 141- 146: dsiqs FlqcC-G ingts CD53_HUMAN : 141- 146: dsiqs Flq-CcG ingts CD53_RAT : 19- 23: ffnfl Fwv-C-G ccilg CD53_RAT : 67- 72: imvva Flg-CmG siken CD63_HUMAN : 68- 73: lflva FvgcC-G acken CD63_HUMAN : 68- 73: lflva Fvg-CcG acken CD63_HUMAN : 142- 146: rmqad Fkc-C-G aanyt CD63_MOUSE : 68- 73: lflva FvgcC-G acken CD63_MOUSE : 68- 73: lflva Fvg-CcG acken CD63_RAT : 68- 73: lflva FvgcC-G acken CD63_RAT : 68- 73: lflva Fvg-CcG acken CD81_HUMAN : 77- 82: mmfvg Flg-CyG aiqes CD81_MOUSE : 77- 82: mmfvg Flg-CyG aiqes CD82_HUMAN : 71- 76: tmlmg Flg-CiG avnev CD82_MOUSE : 71- 76: tivmg Flg-CiG avnev CD9_BOVIN : 72- 77: mmlvg FlgcC-G avqes CD9_BOVIN : 72- 77: mmlvg Flg-CcG avqes CD9_CERAE : 74- 79: mmlvg FlgcC-G avqes CD9_CERAE : 74- 79: mmlvg Flg-CcG avqes CD9_FELCA : 72- 77: mmlvg FlgcC-G avqes CD9_FELCA : 72- 77: mmlvg Flg-CcG avqes CD9_HUMAN : 74- 79: mmlvg FlgcC-G avqes CD9_HUMAN : 74- 79: mmlvg Flg-CcG avqes CD9_MOUSE : 72- 77: mmlvg FlgcC-G avqes CD9_MOUSE : 72- 77: mmlvg Flg-CcG avqes CD9_RAT : 72- 77: mmlvg FlgcC-G avqes CD9_RAT : 72- 77: mmlvg Flg-CcG avqes CO02_HUMAN : 19- 23: tfnfl Fwl-C-G ilila CO02_HUMAN : 71- 76: imilg FlgcC-G aikes CO02_HUMAN : 71- 76: imilg Flg-CcG aikes CO02_HUMAN : 149- 153: vfqee Fkc-C-G lvnga IM23_SCHJA : 70- 75: ilivs FlgcC-G aiken IM23_SCHJA : 70- 75: ilivs Flg-CcG aiken IM23_SCHJA : 142- 146: kiqts Fhc-C-G vkgpd IM23_SCHMA : 70- 75: ilivs FlgcC-G aiken IM23_SCHMA : 70- 75: ilivs Flg-CcG aiken IM23_SCHMA : 142- 146: liqss Fhc-C-G akgpd R 18: 11.5102 21( 21) Q-x(3,4)-C-x(1,2)-G Occurences: 21(21) A15_HUMAN : 140- 147: avdhv QrslsCc-G vqnyt CD37_HUMAN : 147- 154: swdyv QfqlrCc-G whypq CD37_RAT : 147- 154: swdya QfqlrCc-G wqspr CD53_HUMAN : 139- 146: awdsi QsflqCc-G ingts CD53_RAT : 138- 145: awdfi QsqlqCc-G vngss CD63_HUMAN : 139- 146: ildrm QadfkCc-G aanyt CD63_MOUSE : 139- 146: ildkl QkennCc-G asnyt CD63_RAT : 139- 146: ildkl QkenkCc-G asnyt CD81_HUMAN : 85- 92: cygai Qesq-CllG tfftc CD81_MOUSE : 85- 92: cygai Qesq-CllG tfftc CD82_HUMAN : 144- 151: awdyv QaqvkCc-G wvsfy CD82_MOUSE : 144- 151: awdyv QaqvkCc-G wvshy CD9_BOVIN : 80- 87: ccgav Qesq-CmlG lffsf CD9_CERAE : 82- 89: ccgav Qesq-CmlG lffgf CD9_FELCA : 80- 87: ccgav Qesq-CmlG lffgf CD9_HUMAN : 82- 89: ccgav Qesq-CmlG lffgf CD9_MOUSE : 80- 87: ccgav Qesq-CmlG lffgf CD9_RAT : 80- 87: ccgav Qesq-CmlG lffgf CO02_HUMAN : 146- 153: aiivf QeefkCc-G lvnga IM23_SCHJA : 139- 146: tmdki QtsfhCc-G vkgpd IM23_SCHMA : 139- 146: fmnli QssfhCc-G akgpd S 19: 11.5102 35( 21) I-x(2,3)-L-x(3,4)-L Occurences: 35(21) A15_HUMAN : 7- 14: etkpv Itc-Lktl-L iiysf A15_HUMAN : 224- 232: afsql IgmlLacc-L srfit A15_HUMAN : 224- 232: afsql Igm-LlaccL srfit CD37_HUMAN : 11- 20: sclsl IkyfLfvfnL fffvl CD37_RAT : 11- 20: sclsl IkyfLfvfnL fffvl CD53_HUMAN : 87- 94: lmsff Ill-Liil-L aevtl CD53_HUMAN : 91- 99: filll Iil-LaevtL aillf CD53_RAT : 109- 117: vyekk Int-LvaegL ndsiq CD63_HUMAN : 194- 203: gcvek IggwLrknvL vvaaa CD63_MOUSE : 194- 203: gcvet IaiwLrkniL lvaaa CD63_RAT : 194- 203: gcvet IaawLrknvL lvaga CD81_HUMAN : 194- 202: dchqk Idd-LfsgkL yligi CD81_MOUSE : 194- 202: dchqk Ide-LfsgkL yligi CD82_HUMAN : 19- 28: flfnl IffiLgaviL gfgvw CD82_HUMAN : 240- 248: gvgva IielLgmv-L siclc CD82_HUMAN : 240- 248: gvgva Iie-LlgmvL siclc CD82_HUMAN : 241- 248: vgvai Iel-Lgmv-L siclc CD82_MOUSE : 240- 247: agvav Iel-Lglf-L siclc CD9_BOVIN : 25- 32: fwlag Iav-Lsvg-L wlrfd CD9_BOVIN : 143- 152: etlka IhiaLdccgL tgvpe CD9_CERAE : 25- 32: fwlag Iav-Laig-L wlrfd CD9_CERAE : 145- 154: etlka IhyaLdccgL aggve CD9_FELCA : 25- 32: fwlag Iav-Lavg-L wlrfd CD9_FELCA : 143- 152: dtlka IhyaLdccgL aggve CD9_HUMAN : 25- 32: fwlag Iav-Laig-L wlrfd CD9_HUMAN : 145- 154: etlka IhyaLnccgL aggve CD9_MOUSE : 25- 32: fwlag Iav-Laig-L wlrfd CD9_RAT : 25- 32: fwlag Iav-Laig-L wlrfd CO02_HUMAN : 90- 97: lllff Igl-Llil-L lqvat CO02_HUMAN : 90- 98: lllff IgllLill-L qvatg CO02_HUMAN : 90- 98: lllff Igl-LlillL qvatg CO02_HUMAN : 198- 206: tcisf IkdfLakn-L iivig IM23_SCHJA : 20- 27: vfiln Iic-Llcs-L vliga IM23_SCHJA : 20- 29: vfiln IiclLcslvL igaga IM23_SCHJA : 21- 29: filni Icl-LcslvL igaga IM23_SCHJA : 92- 99: yaffl Ivl-Liae-L vaaiv IM23_SCHJA : 116- 124: kidde Int-LmtgaL enpne IM23_SCHMA : 20- 27: vfvln Iic-Llcs-L vliga IM23_SCHMA : 20- 29: vfvln IiclLcslvL igaga IM23_SCHMA : 21- 29: fvlni Icl-LcslvL igaga IM23_SCHMA : 116- 124: ridse Ida-LmtgaL dkptk T 20: 11.5102 36( 21) L-x(0,1)-L-x(0,1)-I Occurences: 36(21) A15_HUMAN : 13- 15: tclkt L-L-I iysfv A15_HUMAN : 13- 16: tclkt L-LiI ysfvf CD37_HUMAN : 8- 11: aqesc LsL-I kyflf CD37_RAT : 8- 11: aqesc LsL-I kyflf CD53_HUMAN : 34- 36: gfgiy L-L-I hnnfg CD53_HUMAN : 88- 91: msffi LlL-I illae CD53_HUMAN : 88- 91: msffi L-LlI illae CD53_HUMAN : 88- 92: msffi LlLiI llaev CD53_HUMAN : 89- 91: sffil L-L-I illae CD53_HUMAN : 89- 92: sffil L-LiI llaev CD53_RAT : 87- 91: msffv LlLlI llaev CD53_RAT : 88- 91: sffvl LlL-I llaev CD53_RAT : 88- 91: sffvl L-LlI llaev CD53_RAT : 89- 91: ffvll L-L-I llaev CD63_HUMAN : 89- 92: tfaif LsL-I mlvev CD63_MOUSE : 89- 92: tfaif LsL-I mlvev CD63_RAT : 89- 92: tfaif LsL-I mlvev CD81_HUMAN : 202- 205: lfsgk LyL-I giaai CD81_MOUSE : 202- 205: lfsgk LyL-I giaai CD82_HUMAN : 92- 95: lyfaf LlL-I liaqv CD82_HUMAN : 92- 95: lyfaf L-LlI liaqv CD82_HUMAN : 93- 95: yfafl L-L-I liaqv CD82_HUMAN : 94- 97: fafll LiL-I aqvta CD82_MOUSE : 92- 95: lyfvf LlL-I liaqv CD82_MOUSE : 92- 95: lyfvf L-LlI liaqv CD82_MOUSE : 93- 95: yfvfl L-L-I liaqv CD82_MOUSE : 94- 97: fvfll LiL-I aqvtv CD82_MOUSE : 245- 249: iellg LfLsI clcry CD9_BOVIN : 93- 96: lffsf L-LvI faiev CD9_CERAE : 95- 98: lffgf L-LvI faiei CD9_FELCA : 93- 96: lffgf L-LvI faiei CD9_HUMAN : 95- 98: lffgf L-LvI faiei CD9_MOUSE : 93- 96: lffgf L-LvI faiei CD9_RAT : 93- 96: lffgf L-LvI faiei CO02_HUMAN : 27- 31: cgili LaLaI wvrvs CO02_HUMAN : 92- 95: lffig LlL-I lllqv CO02_HUMAN : 92- 95: lffig L-LlI lllqv CO02_HUMAN : 93- 95: ffigl L-L-I lllqv IM23_SCHJA : 27- 30: cllcs LvL-I gagay IM23_SCHJA : 94- 96: ffliv L-L-I aelva IM23_SCHJA : 199- 202: vcffq L-LsI viacc IM23_SCHMA : 27- 30: cllcs LvL-I gagay IM23_SCHMA : 94- 96: fflvv L-L-I aelaa IM23_SCHMA : 199- 202: vcffq L-LsI viacc Number of patterns evaluated by Pratt:1711 Total running time: 2 seconds